文献速递乳腺MR

高危乳腺癌MRI筛查:局部评分系统的诊断效能

High-risk breast cancer screening with MRI: diagnostic performance of a local scoring system.
PubMed 文献 · Clin Radiol · 2025-05-22

回顾性分析174例高危乳腺MRI筛查中的73个病灶,采用结合五个MRI描述符的莱斯特评分系统(LSS)进行分类评分;最佳截断值2分时敏感度100%、特异度87.5%(p<0.001),使用LSS可能避免48%的活检,排除IMLN后可达79%,且未遗漏任何癌症。

要点

  • LSS以2分为最佳截断值,敏感度100%、特异度87.5%(p<0.001)。
  • 使用LSS可能避免48%的活检,排除IMLN后可达79%且未遗漏癌症。
  • 典型IMLN在影像上常似恶性,不符合大小标准时应排除评分并视为良性。

核心结论

  • 莱斯特评分系统有潜力避免高达79%的不必要活检而不影响癌症检出;本队列结果挑战了癌症可能仅表现为良性特征的假设。

研究设计与样本

  • 回顾性研究,分析2014-2024年10年间174例高危乳腺MRI筛查中的73个病灶,病灶包括肿块、焦点和线样/导管样非肿块样强化,采用结合边缘、信号模式、内部强化、对比动力学和DWI模式五个MRI描述符的LSS进行分类评分。

关键影像表现/征象

  • 全部10个恶性病灶LSS评分≥2(平均4.6)。
  • 40个良性病灶(排除IMLN)中87.5%评分<2(平均1.1)。
  • 典型IMLN在影像上常似恶性,不符合大小标准时应排除评分并视为良性。

诊断标准与关键数值

  • LSS最佳截断值2分:敏感度100%、特异度87.5%(p<0.001)。
  • 读者间一致性很好,K值0.81(p<0.001)。

临床应用与阅片要点

  • 使用LSS可能避免48%的病灶活检,排除IMLN后可达79%,且未遗漏任何癌症。
  • 典型IMLN在影像上常似恶性,不符合大小标准时应排除评分并视为良性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Breast MRI is widely used for screening high-risk women, though its high cost and false positive rates pose challenges. There is growing research exploring the potential integration of breast MRI into the screening of other patient groups, including women with dense breasts and/or an intermediate lifetime risk for breast cancer. We evaluated the diagnostic performance of Leicester scoring system (LSS) in managing lesions detected at high-risk screening breast MRI.

MATERIALS AND METHODS: In this retrospective study, 73 lesions from 174 high-risk breast MRI studies over a 10-year period (2014-2024) were analyzed. Included lesions were masses, foci, and linear/ductal non-mass-like enhancement. Lesions were classified and scored using the LSS, which combines five MRI descriptors: margins, signal patterns, internal enhancement, contrast kinetics, and DWI patterns.

RESULTS: All 10 malignant lesions had LSS scores ≥2 (mean: 4.6). Of the 40 benign lesions (excluding IMLNs), 87.5% had scores <2 (mean: 1.1). The optimal cut-off of 2 achieved 100% sensitivity and 87.5% specificity (p<0.001). Typical IMLNs, which often mimic malignancy on imaging, should be excluded from scoring and considered benign when they are not significant by size criteria. Using LSS could potentially avoid biopsy in 48% of lesions, or up to 79% if IMLNs are excluded, without missing any cancers. The inter-reader agreement was very good, with a K-value of 0.81 (p<0.001).

CONCLUSION: Leicester Scoring System has the potential to avoid up to 79% of unnecessary biopsies without compromising cancer detection. Our results challenge the assumption that cancers may present with exclusively benign features in this cohort of women.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ziada K, Siu M, Gatt R, et al. High-risk breast cancer screening with MRI: diagnostic performance of a local scoring system. Clin Radiol. 2025. PMID: 40554189. doi:10.1016/j.crad.2025.106968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。